Traumatic Brain Injury Biomarkers Market

The Traumatic Brain Injury (TBI) Biomarkers market involves the development and use of biological indicators, like proteins and metabolites, to diagnose and manage brain injuries. The primary customers are clinicians within hospitals, clinics, and diagnostic laboratories who require objective data for patient care. Key growth drivers include the rising global incidence of TBIs, technological advancements leading to more precise biomarkers, and strong demand for noninvasive and rapid diagnostic solutions.